Na Ge Selected Research

aplysin

5/2021	Retraction Note to: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR‑181 level.
10/2018	Aplysin Protects Against Alcohol-Induced Liver Injury Via Alleviating Oxidative Damage and Modulating Endogenous Apoptosis-Related Genes Expression in Rats.
1/2017	Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats.
5/2015	Aplysin induces apoptosis in glioma cells through HSP90/AKT pathway.
9/2014	Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Na Ge Research Topics

Disease

6	Diabetic Nephropathies (Diabetic Nephropathy) 02/2024 - 04/2013
4	Neoplasms (Cancer) 04/2024 - 09/2014
3	Type 2 Diabetes Mellitus (MODY) 02/2024 - 01/2018
3	Hypertrophy 01/2022 - 01/2018
3	Glioma (Gliomas) 05/2021 - 09/2014
3	Body Weight (Weight, Body) 10/2018 - 04/2013
2	Dehydration (Water Stress) 03/2023 - 12/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Hyperglycemia 01/2019
1	Malaria 01/2019
1	Albuminuria 07/2018
1	Inflammation (Inflammations) 01/2017
1	Pharyngitis (Sore Throat) 12/2015
1	Hypoxia (Hypoxemia) 12/2015
1	Heart Failure 01/2014
1	Bacterial Infections (Bacterial Infection) 01/2014
1	Fever (Fevers) 01/2014
1	Proteinuria 04/2013
1	Fibrosis (Cirrhosis) 04/2013

Drug/Important Bio-Agent (IBA)

5	aplysinIBA 05/2021 - 09/2014
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2014
3	AlbuminsIBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 03/2023 - 12/2021
2	Artemether FDA Link 01/2022 - 01/2019
2	Temozolomide (Temodar)FDA LinkGeneric 05/2021 - 09/2014
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
2	Streptozocin (Streptozotocin)FDA Link 07/2018 - 04/2013
2	Niclosamide FDA Link 01/2018 - 01/2018
1	NF-kappa B (NF-kB)IBA 04/2024
1	VimentinIBA 04/2024
1	Cadherins (E-Cadherin)IBA 04/2024
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2024
1	Amino Acids FDA Link 01/2022
1	AntioxidantsIBA 12/2021
1	Glutathione (Reduced Glutathione)IBA 12/2021
1	N-methyladenosineIBA 01/2021
1	EnzymesIBA 01/2021
1	triptolideIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Ether (Diethyl Ether)IBA 01/2019
1	artemisinin (artemisinine)IBA 01/2019
1	Monocarboxylic Acid TransportersIBA 01/2019
1	CreatinineIBA 07/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2018
1	Lipocalin-2IBA 07/2018
1	Blood Glucose (Blood Sugar)IBA 07/2018
1	astragaloside AIBA 07/2018
1	Acetylglucosaminidase (NAGase)IBA 07/2018
1	SaltsIBA 01/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2018
1	Ethanolamine (Colamine)IBA 01/2018
1	LuciferasesIBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 09/2014
1	EndotoxinsIBA 01/2014
1	ProcalcitoninIBA 01/2014
1	Perindopril FDA LinkGeneric 04/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2013
1	CollagenIBA 04/2013
1	lumbrokinaseIBA 04/2013
1	Therapeutic UsesIBA 04/2013
1	Matrix Metalloproteinases (MMPs)IBA 04/2013

Therapy/Procedure

1	Therapeutics 01/2022
1	Anesthesia 12/2015